Seelos Therapeutics (NASDAQ: SEEL)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-05 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-05-31 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Seelos Therapeutics (NASDAQ: SEEL) through any online brokerage.
Other companies in Seelos Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), Iterum Therapeutics (NASDAQ:ITRM), WAVE Life Sciences (NASDAQ:WVE), SCYNEXIS (NASDAQ:SCYX) and Terns Pharma (NASDAQ:TERN).
The latest price target for Seelos Therapeutics (NASDAQ: SEEL) was reported by B. Riley Securities on Monday, March 14, 2022. The analyst firm set a price target for 4.00 expecting SEEL to rise to within 12 months (a possible 576.93% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Seelos Therapeutics (NASDAQ: SEEL) is $0.5909 last updated Today at May 19, 2022, 3:00 PM UTC.
There are no upcoming dividends for Seelos Therapeutics.
Seelos Therapeutics’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Seelos Therapeutics.
Seelos Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.